Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8

specific

Stage IV includes: IVA: (T4, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)

23

Centers

25

Active Trials

Cancer Funding

Top Centers for Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
171.7
2
High-Volume Research Center
71.7
3
High-Volume Research Center
71.7
4
NCI Comprehensive
Active Research Program
50.2
5
NCI Comprehensive
Active Research Program
50.2
6
NCI Comprehensive
Active Research Program
50.2
7
NCI Comprehensive
Active Research Program
50.2
8
NCI Comprehensive
Active Research Program
50.2
9
NCI Comprehensive
Active Research Program
50.2
10
NCI Comprehensive
Active Research Program
50.2
11
NCI Comprehensive
Active Research Program
50.2
12
NCI Comprehensive
Active Research Program
50.2
13
NCI Comprehensive
Active Research Program
50.2
14
NCI Clinical
Active Research Program
50.2
15
NCI Comprehensive
Active Research Program
50.2
16
Active Research Program
50.2
17
Active Research Program
50.2
18
Active Research Program
50.2
19
NCI Comprehensive
Active Research Program
50.2
20
Active Research Program
50.2
21
Active Research Program
50.2
22
Active Research Program
50.2
23
NCI Comprehensive
30.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →